Integragen (France) Analysis
| ALINT Stock | EUR 0.48 0.01 2.04% |
Integragen is overvalued with Real Value of 0.41 and Hype Value of 0.48. The main objective of Integragen stock analysis is to determine its intrinsic value, which is an estimate of what Integragen is worth, separate from its market price. There are two main types of Integragen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Integragen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Integragen's stock to identify patterns and trends that may indicate its future price movements.
The Integragen stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Integragen is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day. Integragen Stock trading window is adjusted to Europe/Paris timezone.
Integragen |
Integragen Stock Analysis Notes
About 66.0% of the company shares are held by company insiders. The book value of Integragen was presently reported as 0.31. The company had not issued any dividends in recent years. IntegraGen SA provides human genome analysis services for academic and private laboratories in France and the United States. IntegraGen SA was founded in 2000 and is headquartered in vry, France. INTEGRAGEN operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 43 people. For more info on Integragen please contact MBA DVM at 33 1 60 91 09 00 or go to https://integragen.com.Integragen Investment Alerts
| Integragen generated a negative expected return over the last 90 days | |
| Integragen has high historical volatility and very poor performance | |
| Integragen has some characteristics of a very speculative penny stock | |
| Integragen has accumulated about 1.84 M in cash with (2.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 66.0% of the company shares are held by company insiders |
Integragen Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integragen's market, we take the total number of its shares issued and multiply it by Integragen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Integragen Profitablity
Integragen's profitability indicators refer to fundamental financial ratios that showcase Integragen's ability to generate income relative to its revenue or operating costs. If, let's say, Integragen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Integragen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Integragen's profitability requires more research than a typical breakdown of Integragen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Technical Drivers
As of the 4th of December, Integragen retains the Standard Deviation of 5.0, risk adjusted performance of 0.0079, and Market Risk Adjusted Performance of 0.0284. Integragen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Integragen Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Integragen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Integragen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Integragen Outstanding Bonds
Integragen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Integragen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Integragen bonds can be classified according to their maturity, which is the date when Integragen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Integragen Predictive Daily Indicators
Integragen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Integragen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Integragen Forecast Models
Integragen's time-series forecasting models are one of many Integragen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Integragen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Integragen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Integragen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Integragen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Integragen. By using and applying Integragen Stock analysis, traders can create a robust methodology for identifying Integragen entry and exit points for their positions.
IntegraGen SA provides human genome analysis services for academic and private laboratories in France and the United States. IntegraGen SA was founded in 2000 and is headquartered in vry, France. INTEGRAGEN operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 43 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Integragen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.